Search
Cookie policy
Introduction
When you visit the EHA website and/or EHA’s resource platform(s) (this includes all websites and pages, with the exemption of www. t2evolve.
First CMML guidelines produced by EHA, now available
Chronic myelomonocytic leukemia (CMML) is a rare disease with overlapping features of two categories of bone marrow and blood cell disorders that poses challenges in clinical management.
Read moreAddressing immunoglobulin shortages: EHA and EBA’s strategic recommendations at the EMA
In recent years, shortages of immunoglobulins (Ig) have become a growing concern in the European Union (EU). Since 2018, the European Medicines Agency (EMA)—the EU agency that evaluates and supervises medicines—has received an increasing number of shortage reports.
Read moreNational Society Day 2025
Presentations from the National Society Days held by EHA on February 13 and 14, 2025.
Read moreSponsors
If you want to go fast, go alone. If you want to go far, go together. We aim for long-term relationships with our partners and sponsors.
Read moreResearch Committee call for interest
The overarching aim of the Research Committee is to further strengthen EHA’s interactions with and relevance for the wider hematological research community.
Read moreInternational Call to Action to Alleviate Drug Shortages
The common call to action seeks first to raise awareness of shortages of drugs among hematologists.
Read more